Advertisement

Topics

Can this British Biotech Overcome Failure buying drugs from AstraZeneca?

09:52 EDT 17 Mar 2017 | Labiotech.eu

After the big disaster with its cat allergy vaccine, Circassia closes a €214M deal to acquire rights from two AstraZeneca products for pulmonary disease. Circassia could not beat the placebo in a Phase III trial for cat allergy last year, ...

This awesome article Can this British Biotech Overcome Failure buying drugs from AstraZeneca? appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Can this British Biotech Overcome Failure buying drugs from AstraZeneca?

NEXT ARTICLE

More From BioPortfolio on "Can this British Biotech Overcome Failure buying drugs from AstraZeneca?"

Quick Search
Advertisement
 

Relevant Topic

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...